Medical Condition News

RSS

Traditional Japanese medicine for obesity may help reduce age-related tissue fibrosis

A traditional Japanese medicine used for obesity may do more than support weight loss. Researchers at the University of Osaka, working with Kobayashi Pharmaceutical Co., Ltd. investigated whether Bofutsushosan could protect aging tissues from fibrosis - the excessive buildup of scar-like tissue that can make organs stiff and less functional.

2 Aug 2026

Immune cell changes provide new insights into long COVID

Extreme fatigue, a racing pulse, shortness of breath, brain fog, aching joints-the symptoms of long COVID can vary widely, change unpredictably, and be difficult to even recognize as signs of the condition.

2 Aug 2026

Daytime cortisol patterns track cognitive decline but not Alzheimer’s disease risk

In 3,895 older adults, moderate daytime cortisol variability was associated with better cognition and slower decline, while the highest daily cortisol exposure was linked to poorer cognition and faster decline. Cortisol patterns differed between Black and White participants, but their relationships with cognition were similar, and none predicted incident Alzheimer’s disease.

2 Aug 2026

Cooperative sperm may improve fertilization success across diverse arthropods

Fertilization is often imagined as a frantic race, with millions of sperm competing for a single prize. But new research by a team of evolutionary biologists from Syracuse University, University of Siena, Italy, and University of Szeged, Hungary, reveals a more surprising reality, where success can depend less on competition and more on cooperation.

31 Jul 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

31 Jul 2026

Review outlines effective approaches to reduce recurrent hepatic encephalopathy

Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality.

31 Jul 2026

Study offers a potential strategy to make nanoparticle-based cancer drugs more effective

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, offering a potential strategy to make nanoparticle-based cancer drugs more effective.

31 Jul 2026

Arginine boosts immune defenses against cancer and viral infections

The amino acid arginine helps to keep the human body humming, most notably by synthesizing proteins that carry out a range of cellular processes.

31 Jul 2026

Scientists map protective cell networks hiding dormant breast tumor cells

Researchers at the MRC Laboratory of Medical Sciences (LMS), Imperial College London and UCL Genetics Institute have created a detailed map of cells within breast tumors and identified distinct neighborhoods of proliferating and dormant cells.

31 Jul 2026

Researchers propose new framework to define clinical obesity

A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and tissues rather than relying primarily on whether a person meets a set of metabolic risk thresholds.

31 Jul 2026

Genetic variants interact to increase early-onset atrial fibrillation risk

An estimated 10 million Americans have atrial fibrillation (AFib), according to the National Institutes of Health's National Heart, Lung, and Blood Institute.

31 Jul 2026

URI professor wins $1.5M grant to study cerebral amyloid angiopathy

A $1.5M grant has been awarded to William Van Nostrand, co-executive director of the University of Rhode Island's George & Anne Ryan Institute for Neuroscience and professor of pharmaceutical and biomedical sciences in the URI College of Pharmacy, to study cerebral amyloid angiopathy (CAA), a disease prevalent in the elderly population and commonly found in patients with Alzheimer's disease.

31 Jul 2026

Accumulation of somatic mutations drives vascular damage in people with progeria

Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disorder that causes remarkable premature aging.

31 Jul 2026

Soy lysolecithin reduces salt-induced hypertension and cognitive decline

High salt (HS) intake is a major global health concern, closely linked to hypertension and growing evidence of cognitive and emotional decline.

31 Jul 2026

Mouse study links leaky gut to severe food allergies

A "leaky gut" might increase the severity of food allergies, according to new research conducted in mice and published in The Journal of Immunology.

31 Jul 2026

New stem cell vesicles accelerate diabetic wound healing

Diabetic foot ulcers are among the most serious complications of diabetes because prolonged inflammation, poor circulation, and defective angiogenesis can leave wounds open for months and increase the risk of infection and amputation.

31 Jul 2026

Hydrogen-powered shipping could deliver $284 billion in annual health benefits

Researchers modeled how replacing conventional global shipping fuels with hydrogen could change PM2.5 and ozone pollution, premature mortality, and monetized health benefits. Under complete transition, the model estimated 129,458 fewer premature deaths and US$284 billion in annual monetized health benefits, although some regions experienced increased pollution from hydrogen production or altered ozone chemistry.

31 Jul 2026

Research identifies common neuroimmune signatures in rapid-acting antidepressants

In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine and psychedelics, can reduce symptoms in difficult-to-treat depression.

30 Jul 2026

QUANTUM trial tests immune-targeting approach for primary plasma cell leukemia

The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (PCL).

30 Jul 2026